A diabetic mother saddled with medical debt from type 1 diabetes (T1D) treatments and complications is highlighting the rising costs of insulin and T1D care in the United States, Forbes reports.

Faced with the threat of regulations and accusations of targeting minors with vaping products and marketing, Juul Labs announced Nov. 13 it would suspend retail sales of most of its flavored e-cigarette pods and shut down social media promotions.

Cancer is overtaking heart disease as the leading cause of death in the U.S., particularly in high-income counties, suggests a new analysis published in the Annals of Internal Medicine.

Physicians who have financial relationships with biomedical manufacturers are up to 12 times more likely to use an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D) from that company instead of another manufacturer, according to preliminary research presented at the American Heart Association Scientific Sessions in Chicago.

IBM Watson Health has released its annual 50 Top Cardiovascular Hospitals Study, marking the 20th year the healthcare company has ranked the best-performing cardiovascular teaching and community hospitals in the U.S.

While many Americans were fixated on the Congressional races during the Nov. 6 midterm elections, the American Heart Association and CEO Nancy Brown kept an eye on ballot measures with implications for cardiovascular health.

A clinical and economic analysis of PCSK9 inhibitors in Canadian patients with atherosclerotic cardiovascular disease (ASCVD) is solidifying physician concerns that the lipid-lowering drugs might be too inaccessible—or too pricey—to benefit the average heart patient.

Mandatory CPR training in high school may contribute to higher rates of bystander intervention and improved survival following out-of-hospital cardiac arrest (OHCA), according to a registry study slated to be presented Nov. 11 at the American Heart Association’s Resuscitation Science Symposium in Chicago.